Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amino acid peritoneal dialysis solutions are specialized intraperitoneal fluids used in patients undergoing peritoneal dialysis, particularly those with protein malnutrition. These solutions contain a mixture of essential and non-essential amino acids (such as histidine, valine, isoleucine, alanine, leucine, arginine, lysine, glycine, methionine, proline, phenylalanine, serine, threonine, tyrosine and tryptophan) formulated to compensate for protein losses during dialysis and to provide a source of nutrition when dietary intake is insufficient[4][5]. The mechanism of action involves the absorption of amino acids from the dialysate into the bloodstream through the peritoneum; this stimulates protein synthesis and inhibits protein breakdown—mimicking an anabolic response similar to food intake[1][2]. These solutions may be used alone or in combination with glucose-containing dialysates to optimize both caloric and protein delivery. They are indicated for treating or preventing malnutrition in chronic kidney disease patients on continuous ambulatory or automated peritoneal dialysis who cannot meet nutritional requirements through diet alone[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amino acid peritoneal dialysis solution.